Dipeptidyl peptidase-4 inhibitors and the risk of heart failure: a systematic review and meta-analysis

BACKGROUND: Given recent discrepant results from randomized controlled trials (RCTs), we examined the totality of RCT evidence assessing the association between dipeptidyl peptidase-4 (DPP-4) inhibitors and heart failure. METHODS: MEDLINE, Embase and ClinicalTrials.gov were searched without language...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:CMAJ Open
Main Authors: Verma, Subodh, Goldenberg, Ronald M., Bhatt, Deepak L., Farkouh, Michael E., Quan, Adrian, Teoh, Hwee, Connelly, Kim A., Leiter, Lawrence A., Friedrich, Jan O.
Formato: Artigo
Idioma:Inglês
Publicado: Joule Inc. or its licensors 2017
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5403656/
https://ncbi.nlm.nih.gov/pubmed/28459046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9778/cmajo.20160058
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares